DE69423533T2 - Zubereitungen zur Behandlung von Impotenz, die ein Alpha-1 inhibitor und ein Alpha-2 inhibitor enthalten - Google Patents

Zubereitungen zur Behandlung von Impotenz, die ein Alpha-1 inhibitor und ein Alpha-2 inhibitor enthalten

Info

Publication number
DE69423533T2
DE69423533T2 DE69423533T DE69423533T DE69423533T2 DE 69423533 T2 DE69423533 T2 DE 69423533T2 DE 69423533 T DE69423533 T DE 69423533T DE 69423533 T DE69423533 T DE 69423533T DE 69423533 T2 DE69423533 T2 DE 69423533T2
Authority
DE
Germany
Prior art keywords
alpha
inhibitor
impotence
preparations
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69423533T
Other languages
English (en)
Other versions
DE69423533D1 (de
Inventor
Haralambos Gavras
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BMRA Corp BV
Original Assignee
BMRA Corp BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BMRA Corp BV filed Critical BMRA Corp BV
Publication of DE69423533D1 publication Critical patent/DE69423533D1/de
Application granted granted Critical
Publication of DE69423533T2 publication Critical patent/DE69423533T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
DE69423533T 1993-02-10 1994-01-14 Zubereitungen zur Behandlung von Impotenz, die ein Alpha-1 inhibitor und ein Alpha-2 inhibitor enthalten Expired - Fee Related DE69423533T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1559293A 1993-02-10 1993-02-10

Publications (2)

Publication Number Publication Date
DE69423533D1 DE69423533D1 (de) 2000-04-27
DE69423533T2 true DE69423533T2 (de) 2000-08-24

Family

ID=21772337

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69423533T Expired - Fee Related DE69423533T2 (de) 1993-02-10 1994-01-14 Zubereitungen zur Behandlung von Impotenz, die ein Alpha-1 inhibitor und ein Alpha-2 inhibitor enthalten

Country Status (6)

Country Link
US (1) US5567706A (de)
EP (1) EP0611248B1 (de)
AT (1) ATE190843T1 (de)
DE (1) DE69423533T2 (de)
ES (1) ES2146249T3 (de)
HK (1) HK1011285A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
WO1999059584A1 (en) * 1998-05-20 1999-11-25 Schering Corporation Combination of phentolamine and cyclic gmp phosphodiesterase inhibitors for the treatment of sexual dysfunction
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
US6365590B1 (en) 1998-05-26 2002-04-02 Saint Louis University Compounds, compositions and methods for treating erectile dysfunction
AU3724400A (en) * 1999-03-08 2000-09-28 Merck & Co., Inc. Methods and compositions for treating erectile dysfunction
IT1312310B1 (it) * 1999-05-07 2002-04-15 Recordati Ind Chimica E Farma Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310524A (en) * 1980-04-11 1982-01-12 Richardson-Merrell, Inc. TCA Composition and method for rapid onset antidepressant therapy
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds
US4659714A (en) * 1984-03-27 1987-04-21 Dentsply, Ltd. Anesthetic methods for mammals
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
EP0459666B1 (de) * 1990-05-31 1994-11-09 Pfizer Inc. Arzneimittel gegen Impotenz
US5399581A (en) * 1990-12-26 1995-03-21 Laragh; John H. Method and compositions for treatment of sexual impotence

Also Published As

Publication number Publication date
ATE190843T1 (de) 2000-04-15
EP0611248B1 (de) 2000-03-22
US5567706A (en) 1996-10-22
DE69423533D1 (de) 2000-04-27
HK1011285A1 (en) 1999-07-09
EP0611248A1 (de) 1994-08-17
ES2146249T3 (es) 2000-08-01

Similar Documents

Publication Publication Date Title
DE69805973T2 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
DE69423533T2 (de) Zubereitungen zur Behandlung von Impotenz, die ein Alpha-1 inhibitor und ein Alpha-2 inhibitor enthalten
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
ATE173630T1 (de) Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren
DE69524959T2 (de) Haarpflegezusammensetzungen, die n-vinylformamidepolymer enthalten, und verfahren zur behandlung des haares
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
ATE257385T1 (de) Zusammensetzungen und verfahren zur behandlung des erhöhten augenindruckes
DE69014030T3 (de) Mittel für die Verhütung und Behandlung von Diarrhöe.
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
DE69519937T2 (de) Polyamin-verbindungen zur behandlung von proliferativer erkrankungen
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
DE69511393D1 (de) Polymerzusammensetzung und verfahren zur behandlung von metalloberflächen
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
DE69209588D1 (de) Hochfeste, verschleissfeste Aluminiumlegierung und Verfahren zur Behandlung derselben
DE69429101D1 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
DE69033413T2 (de) Mittel zur Behandlung von Metalloberflächen
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE200026T1 (de) Behandlung von laminitis
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
DE68906651T2 (de) Zusammensetzung und verfahren zur behandlung von metalloberflaechen.
DE69808607T2 (de) Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz
DE69726037D1 (de) Zusammensetzung und Verfahren zur Behandlung von Kulturen gegen Bodenparasitärkomplexe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee